Summary: Mr. Joseph Dasta leads a roundtable discussion with fellow faculty members, Drs. Michael Cawley and Henry Cohen. This discussion was produced by ASHP Advantage and supported by an educational grant from Otsuka America Pharmaceutical, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/hyponatremia

Faculty:

Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair
Professor Emeritus
The Ohio State University College of Pharmacy
Columbus, Ohio
Adjunct Professor
The University of Texas College of Pharmacy
Austin, Texas

Michael J. Cawley, Pharm.D., RRT, CPFT
Associate Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
University of the Sciences
Philadelphia, Pennsylvania

Henry Cohen, M.S., Pharm.D., BCPP, FCCM, CGP
Professor of Pharmacy Practice
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Long Island University
Chief Pharmacotherapy Officer
Kingsbrook Jewish Medical Center
Brooklyn, New York

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Mr. Joseph Dasta leads a roundtable discussion with fellow faculty members, Drs. Michael Cawley and Henry Cohen. This discussion was produced by ASHP Advantage and supported by an educational grant from Otsuka America Pharmaceutical, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/hyponatremia

Faculty:

Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair
Professor Emeritus
The Ohio State University College of Pharmacy
Columbus, Ohio
Adjunct Professor
The University of Texas College of Pharmacy
Austin, Texas

Michael J. Cawley, Pharm.D., RRT, CPFT
Associate Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
University of the Sciences
Philadelphia, Pennsylvania

Henry Cohen, M.S., Pharm.D., BCPP, FCCM, CGP
Professor of Pharmacy Practice
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Long Island University
Chief Pharmacotherapy Officer
Kingsbrook Jewish Medical Center
Brooklyn, New York

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Mr. Joseph Dasta leads a roundtable discussion with fellow faculty members, Drs. Michael Cawley and Henry Cohen. This discussion was produced by ASHP Advantage and supported by an educational grant from Otsuka America Pharmaceutical, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/hyponatremia

Faculty:

Joseph F. Dasta, M.S., FCCM, FCCP, Activity Chair
Professor Emeritus
The Ohio State University College of Pharmacy
Columbus, Ohio
Adjunct Professor
The University of Texas College of Pharmacy
Austin, Texas

Michael J. Cawley, Pharm.D., RRT, CPFT
Associate Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
University of the Sciences
Philadelphia, Pennsylvania

Henry Cohen, M.S., Pharm.D., BCPP, FCCM, CGP
Professor of Pharmacy Practice
Arnold & Marie Schwartz College of Pharmacy and Health Sciences
Long Island University
Chief Pharmacotherapy Officer
Kingsbrook Jewish Medical Center
Brooklyn, New York

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Interview regarding the Stroke Prevention in Atrial Fibrillation: Updated Guidelines and Expanding Treatment Options. This interview was produced by ASHP Advantage and supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/preventstroke

Cynthia A. Sanoski, Pharm.D., FCCP, BCPS, Activity Chair
Chair and Associate Professor
Department of Pharmacy Practice
Jefferson School of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Interview regarding the Stroke Prevention in Atrial Fibrillation: Updated Guidelines and Expanding Treatment Options. This interview was produced by ASHP Advantage and supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/preventstroke

James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)
Senior Manager, Patient Care Services
Department of Pharmacy Services
Henry Ford Hospital
Detroit, Michigan

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Interview regarding the Stroke Prevention in Atrial Fibrillation: Updated Guidelines and Expanding Treatment Options. This interview was produced by ASHP Advantage and supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.ashpadvantage.com/preventstroke

Nancy L. Shapiro, Pharm.D., FCCP, BCPS
Clinical Associate Professor
Operations Manager, Antithrombosis Clinic
The University of Illinois at Chicago College of Pharmacy and Medical Center
Chicago, Illinois

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com.

Craig Martin, Pharm.D., BCPS-ID
Pharmacist, Specialist-Infectious Diseases
Associate Professor of Pharmacy and Medicine
UK HealthCare, University of Kentucky College of Pharmacy
Lexington, Kentucky

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com.

Dennis M. Williams, Pharm.D., BCPS
Associate Professor and Vice Chair
Department of Pharmacotherapy and Experimental Therapeutics
UNC Eshelman School of Pharmacy
University of North Carolina
Chapel Hill, North Carolina

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com.

Joseph Saseen, Pharm.D., FASHP, FCCP, BCPS
Professor, Clinical Pharmacy and Family Medicine
Vice Chair, Department of Clinical Pharmacy
University of Colorado Anschutz Medical Center
Aurora, Colorado

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Interview with CE in the Morning Faculty. This interview was produced by ASHP Advantage and supported by an educational grant from Merck. It was recorded in December 2011 during the 46th ASHP Midyear Clinical Meeting and Exhibition in New Orleans. More information about this topic is available at www.cemornings.com.

Susan Cornell, Pharm.D., CDE, FAPhA, FAADE
Assistant Director of Experiential Education and
Associate Professor of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Downers Grove, Illinois

C.E. Credits: This activity is not eligible for continuing education credits.

Summary: Improvements in cancer treatment have increased survival and the need for effective interventions to reduce the risk for skeletal-related events including pathologic bone fractures, spinal cord compression, need for surgery or radiation therapy to bone, and hypercalcemia of malignancy. Many cancer therapies cause bone loss, which increases the risk for fractures. Bisphosphonates are useful for treating bone metastases and slowing or preventing cancer treatment-induced bone loss (CTIBL). These drugs also may reduce the risk of recurrence and improve survival in patients with early breast cancer or other solid tumors. RANK-ligand Inhibitors have also been shown to decrease skeletal-related events in patients with bone metastases from solid tumors. Other agents for the treatment of bone metastases are under investigation. Knowledge of the role of bisphosphonates and new and emerging bone-targeted therapies in treating patients with bone metastases or CTIBL will enable pharmacists to take an active role in the management of these patients.

Chad M. Barnett, Pharm.D., BCOP
Co-Chair
Clinical Pharmacy Specialist Breast Oncology
Division of Pharmacy
University of Texas M.D. Anderson Cancer Center
Houston, Texas

C.E. Credits: This activity was recorded on April 14, 2011. Continuing education credit for this podcast is available through May 23, 2012. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Advantage CE Testing Center.

Summary: The content for this podcast was adapted from an interview with Paul Dobesh recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Dobesh is Associate Professor of Pharmacy Practice at the University of Nebraska Medical Center in Omaha. He also is chair of this educational initiative coordinated by ASHP Advantage.

Paul P. Dobesh, Pharm.D., FCCP, BCPS (AQ Cardiology)
Associate Professor of Pharmacy Practice
College of Pharmacy
University of Nebraska Medical Center
Omaha, Nebraska

C.E. Credits: Not available for this activity.

Summary: The content for this podcast was adapted from an interview with Julie Oestreich recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Oestreich is Assistant Professor in the Department of Pharmacy Practice in the College of Pharmacy at the University of Nebraska Medical Center (UNMC) in Omaha.

Dr. Oestreich discusses some of the clinical challenges in oral antiplatelet therapy, especially as they relate to platelet function and genetic testing.

Julie H. Oestreich, Pharm.D., Ph.D.
Assistant Professor of Pharmacy Practice
College of Pharmacy
University of Nebraska Medical Center
Omaha, Nebraska

C.E. Credits: Not available for this activity.

Summary: The content for this podcast was adapted from an interview with Toby Trujillo recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Trujillo is Associate Professor of Clinical Pharmacy at the University of Colorado Denver School of Pharmacy in Aurora, Colorado. He also serves as Clinical Specialist in cardiovascular pharmacotherapy and anticoagulation at University of Colorado Hospital.

Dr. Trujillo discusses issues related to current options for managing antiplatelet therapy in patients with acute coronary syndrome.

Toby C. Trujillo, Pharm.D., BCPS (AQ Cardiology)
Associate Professor
University of Colorado Denver School of Pharmacy
Clinical Specialist – Cardiology/Anticoagulation
University of Colorado Hospital
Aurora, Colorado

C.E. Credits: Not available for this activity.

Summary: The content for this podcast was adapted from an interview with Ann Wittkowsky that was recorded on December 5th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Wittkowsky is Clinical Professor at the University of Washington School of Pharmacy, and Director of Anticoagulation Services at the University of Washington Medical Center in Seattle, Washington.

Dr. Wittkowsky will discuss the Role of the Pharmacist in Identifying and Overcoming Barriers to Appropriate and Well-managed Antithrombotic Therapy.

Ann K. Wittkowsky, Pharm.D., CACP, FASHP, FCCP
Clinical Professor
University of Washington School of Pharmacy
Director, Anticoagulation Services
University of Washington Medical Center
Seattle, Washington

C.E. Credits: Not available for this activity.

Summary: The content for this podcast was adapted from an interview with Cynthia Sanoski that was recorded on December 5th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Sanoski is Chair and Associate Professor of the Department of Pharmacy Practice at Jefferson School of Pharmacy, Thomas Jefferson University in Philadelphia, Pennsylvania.

Dr. Sanoski will discuss Stroke Prevention in Atrial Fibrillation: Reviewing the Basics.

Cynthia A. Sanoski, Pharm.D., FCCP, BCPS, Initiative Chair
Chair and Associate Professor
Department of Pharmacy Practice
Jefferson School of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania

C.E. Credits: Not available for this activity.

Summary: The content for this podcast was adapted from an interview with James Kalus that was recorded on December 6th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Kalus is Senior Manager, Patient Care Services of the Department of Pharmacy Services at Henry Ford Hospital in Detroit, Michigan.

Dr. Kalus will discuss Future Directions: Emerging Therapies for Stroke Prevention in Atrial Fibrillation.

James S. Kalus, Pharm.D., BCPS (AQ-Cardiology)
Senior Manager, Patient Care Services
Department of Pharmacy Services
Henry Ford Hospital
Detroit, Michigan

C.E. Credits: Not available for this activity.

Summary: The content for this podcast was adapted from an interview with JoAnn Stubbings recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Ms. Stubbings is Manager of Research and Public Policy in the Ambulatory Care Pharmacy Department at the University of Illinois (UIC) at Chicago College of Pharmacy and Clinical Associate Professor in the Department of Pharmacy Practice. She also serves as chair of the risk evaluation and mitigation strategies educational initiative coordinated by ASHP Advantage.

Ms. Stubbings will discuss practical applications and opportunities presented by REMS.

JoAnn Stubbings, MHCA, B.S. Pharm.
Clinical Associate Professor
Manager, Research and Public Policy
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois

C.E. Credits: Not available for this activity.

Summary: The content for this podcast was adapted from an interview with Stephen Goldman recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Goldman is an independent consultant with extensive experience in academic and clinical medicine, public health, federal medical product safety regulations, and the pharmaceutical industry.

Stephen A. Goldman, M.D., FAPM, DFAPA
Former Medical Director, MedWatch,U.S. Food and Drug Administration
Managing Member, Stephen A. Goldman Consulting Services, LLC
Morris Plains, New Jersey

C.E. Credits: Not available for this activity.

James H. Hoffman, Pharm.D.
Medication Safety Officer
St. Jude Children’s Hospital
Memphis, Tennessee

Ajay K. Singh, MBBS
Associate Professor of Medicine at the Brigham and Women’s Hospital
and Harvard Medical School
Boston, Massachusetts

The content for this podcast was adapted from a dialog that was recorded on August 23, 2010 in Boston, Massachusetts between James H. Hoffman and Ajay K. Singh. The dialog focuses on the various clinical and regulatory aspects concerning the eventual introduction of biosimilars in the United States. After considerable debate, recent legislation has provided a legal framework for the approval of biosimilars in the U.S. Although certain details of the regulatory process still need to be resolved and the first biosimilar may not be approved for another year or two, health care professionals will need to be educated about biosimilars in order to make sound policy and clinical decisions regarding their use.

C.E. Credits: Not available for this activity.

Additional Information: www.biosimcentral.org

James H. Hoffman, Pharm.D.
Medication Safety Officer
St. Jude Children’s Hospital
Memphis, Tennessee

Ajay K. Singh, MBBS
Associate Professor of Medicine at the Brigham and Women’s Hospital
and Harvard Medical School
Boston, Massachusetts

The content for this podcast was adapted from a dialog that was recorded on August 23, 2010 in Boston, Massachusetts between James H. Hoffman and Ajay K. Singh. The dialog focuses on the various clinical and regulatory aspects concerning the eventual introduction of biosimilars in the United States. After considerable debate, recent legislation has provided a legal framework for the approval of biosimilars in the U.S. Although certain details of the regulatory process still need to be resolved and the first biosimilar may not be approved for another year or two, health care professionals will need to be educated about biosimilars in order to make sound policy and clinical decisions regarding their use.

C.E. Credits: Not available for this activity.

Additional Information: www.biosimcentral.org

Part 2:
Case Study: A Tech-Check-Tech Pilot Study in an Academic Medical Center
Beth S. Williams, Pharm.D., BCPS
(30 minutes)

Part 3:
Trained, Tested, and Trusted: PTCB Update
Miriam A. Mobley Smith, B.S.Pharm., Pharm.D.

Summary: Pharmacy Technicians' roles in the pharmacy continue to change as the responsibilities of pharmacists expand. Working under the supervision of the pharmacist, technicians are now performing duties that allow the pharmacist greater flexibility for direct patient care and implementation of new programs. This activity will highlight innovative practices for pharmacy technicians that advance the entire pharmacy team, and outline the benefits of Pharmacy Technician Certification Board (PTCB) certification in seeking these career paths.

Continuing Education
The activity was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until August 31, 2011, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit. The ACPE activity number for pharmacists is 204-000-09-201-H01P and the ACPE activity number for technicians is 204-000-09-201-H01T.

Credits: This activity provides 2 hours (0.2 CEUs) of continuing education credit
Expected Duration: 2 hours
Post Test: Visit www.ashpadvantage.com/podcasts

This activity is planned and coordinated by ASHP Advantage.
It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB).

Part 1:
Innovative Pharmacy Technician Roles in Action
Rowell Daniels, Pharm.D., M.S.

Part 3:
Trained, Tested, and Trusted: PTCB Update
Miriam A. Mobley Smith, B.S.Pharm., Pharm.D.

Summary: Pharmacy Technicians' roles in the pharmacy continue to change as the responsibilities of pharmacists expand. Working under the supervision of the pharmacist, technicians are now performing duties that allow the pharmacist greater flexibility for direct patient care and implementation of new programs. This activity will highlight innovative practices for pharmacy technicians that advance the entire pharmacy team, and outline the benefits of Pharmacy Technician Certification Board (PTCB) certification in seeking these career paths.

Continuing Education
The activity was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until August 31, 2011, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit. The ACPE activity number for pharmacists is 204-000-09-201-H01P and the ACPE activity number for technicians is 204-000-09-201-H01T.

Credits: This activity provides 2 hours (0.2 CEUs) of continuing education credit
Expected Duration: 2 hours
Post Test: Visit www.ashpadvantage.com/podcasts

This activity is planned and coordinated by ASHP Advantage.
It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB).

Part 1:
Innovative Pharmacy Technician Roles in Action
Rowell Daniels, Pharm.D., M.S.

Part 2:
Case Study: A Tech-Check-Tech Pilot Study in an Academic Medical Center
Beth S. Williams, Pharm.D., BCPS

Summary: Pharmacy Technicians' roles in the pharmacy continue to change as the responsibilities of pharmacists expand. Working under the supervision of the pharmacist, technicians are now performing duties that allow the pharmacist greater flexibility for direct patient care and implementation of new programs. This activity will highlight innovative practices for pharmacy technicians that advance the entire pharmacy team, and outline the benefits of Pharmacy Technician Certification Board (PTCB) certification in seeking these career paths.

Continuing Education
The activity was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until August 31, 2011, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit. The ACPE activity number for pharmacists is 204-000-09-201-H01P and the ACPE activity number for technicians is 204-000-09-201-H01T.

Credits: This activity provides 2 hours (0.2 CEUs) of continuing education credit
Expected Duration: 2 hours
Post Test: Visit www.ashpadvantage.com/podcasts

This activity is planned and coordinated by ASHP Advantage.
It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB).

Part 1:
Innovative Pharmacy Technician Roles in Action
Rowell Daniels, Pharm.D., M.S.

Part 2:
Case Study: A Tech-Check-Tech Pilot Study in an Academic Medical Center
Beth S. Williams, Pharm.D., BCPS

Part 3:
Trained, Tested, and Trusted: PTCB Update
Miriam A. Mobley Smith, B.S.Pharm., Pharm.D.

Summary: Pharmacy Technicians' roles in the pharmacy continue to change as the responsibilities of pharmacists expand. Working under the supervision of the pharmacist, technicians are now performing duties that allow the pharmacist greater flexibility for direct patient care and implementation of new programs. This activity will highlight innovative practices for pharmacy technicians that advance the entire pharmacy team, and outline the benefits of Pharmacy Technician Certification Board (PTCB) certification in seeking these career paths.

Continuing Education
The activity was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until August 31, 2011, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Advantage CE Testing Center. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit. The ACPE activity number for pharmacists is 204-000-09-201-H01P and the ACPE activity number for technicians is 204-000-09-201-H01T.

Credits: This activity provides 2 hours (0.2 CEUs) of continuing education credit
Expected Duration: 2 hours
Post Test: Visit www.ashpadvantage.com/podcasts

This activity is planned and coordinated by ASHP Advantage.
It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB).

Dr. Scott T. Micek, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, was interviewed by 17 radio stations, including CNN Radio. The interviews were designed to educate consumers about the vital patient-care role pharmacists play in hospitals and health systems. This podcast includes the interview with WIBW in Topeka, Kansas. Permission to share this interview with the public was granted by the Kansas Information Network and James Doblin, who conducted the interview.)

The Barnes-Jewish Hospital's team, which was led by Dr. Micek, received the 2007 Award for Excellence in Medication-Use Safety. The ASHP Foundation created the Award for Excellence in Medication-Use Safety in 2004. It is the only award program to honor a pharmacist-led, multidisciplinary team for its significant institution-wide system improvements relating to medication use. The $50,000 award recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award is sponsored by the Cardinal Health Foundation. For more information, please visit www.ashpfoundation.org.

Dr. Scott T. Micek, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, was interviewed by 17 radio stations, including CNN Radio. The interviews were designed to educate consumers about the vital patient-care role pharmacists play in hospitals and health systems. This podcast includes the interview with WIBW in Topeka, Kansas. Permission to share this interview with the public was granted by the Kansas Information Network and James Doblin, who conducted the interview.)

The Barnes-Jewish Hospital's team, which was led by Dr. Micek, received the 2007 Award for Excellence in Medication-Use Safety. The ASHP Foundation created the Award for Excellence in Medication-Use Safety in 2004. It is the only award program to honor a pharmacist-led, multidisciplinary team for its significant institution-wide system improvements relating to medication use. The $50,000 award recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award is sponsored by the Cardinal Health Foundation. For more information, please visit www.ashpfoundation.org.